FDA grants accelerated approval to talquetamab-tgvs for relapsed or refractory multiple myeloma August 10, 2023 AutoBot News 0 On August 9, 2023, the Food and Drug Administration granted accelerated approval to talquetamab-tgvs (Talvey, Janssen Biotech, Inc.)